352 results
Page 6 of 18
8-K
EX-99.2
69u60lojtb2l0fw92qam
20 Apr 15
Data Presented at American Association for Cancer Research 2015 Annual Meeting
12:00am
8-K
EX-99.1
tpg1m8082c6
20 Apr 15
Data Presented at American Association for Cancer Research 2015 Annual Meeting
12:00am
8-K
EX-99.1
5qjtfnhla ac28i
24 Feb 15
BioTime Announces First Patient Treated in Pivotal Clinical Trial of Renevia™ for HIV-Associated Lipoatrophy
12:00am
8-K
EX-99.1
0agircbysgz75ba
6 Feb 15
OncoCyte to Present Cancer Diagnostic Clinical Study Data at AACR Annual Meeting
12:00am
8-K
EX-99.1
tbhqov2ixoz
26 Jan 15
BioTime Announces Issuance of 14 New Patents in the Fields of Regenerative Medicine, Stem Cell Technology, and Cancer Therapy
12:00am
8-K
EX-99.1
seumyi4xkre6
12 Jan 15
BioTime Subsidiary OncoCyte Corporation Appoints William Annett to Its Board of Directors
12:00am
8-K
EX-99.1
ovgnfcyh 0i68p4dz
29 Dec 14
BioTime Appoints Adi Mohanty Chief Operating Officer
12:00am
8-K
EX-99.1
b9z8gq5qi8s2q7y6o
15 Dec 14
BioTime Appoints Angus C. Russell to Board of Directors
12:00am
8-K
EX-99.1
nybpjaxo oojc6dd0mc
15 Dec 14
Regulation FD Disclosure
12:00am
8-K
EX-99.2
2jm5mh st0i6xti
15 Dec 14
BioTime Appoints Angus C. Russell to Board of Directors
12:00am
8-K
EX-99.1
j15b1 c22a1
4 Dec 14
BioTime to Present at the LD Micro VII Conference
12:00am
8-K
EX-99.1
yhbkb vsc0je2tib720u
10 Nov 14
BioTime Reports Third Quarter Results and Recent Progress
12:00am
8-K
EX-99.1
5iwajzn4pq87fcr6p
3 Nov 14
Other Events
12:00am
8-K
EX-99.1
m45h6mc80ic81e2
9 Oct 14
BioTime, Inc. Closes $31 Million Financing
12:00am
8-K
EX-99.3
poolmxfnqyos5h9n6lu
6 Oct 14
Departure of Directors or Certain Officers
12:00am